IN MY OPINIONCONTENTSLAST WORDSamir Ounzain,Co-founder,Chief Executive Officer and Board Director, HAYA TherapeuticsTHE DARK SIDE OF THE GENOME TRANSFORMING RNA THERAPIES08Almudena Trigo,Founding Partner and Chairwoman, BeAble CapitalINVESTING IN INDUSTRIAL BIOTECH STARTUPS30A STRATEGIC PARTNER FOR GROWTH-DRIVEN BIOTECH VENTURESALMARALMaria Severina,Founder and CEOCOVER STORY 12 LIFE SCIENCESCONSULTINGCOMPANY OFTHE YEARIN EUROPE2024
< Page 3 | Page 5 >